Clinical trials
PARKINSON DISEASE (Disorder) clinical trials
Below are recruiting parkinson disease (disorder) clinical trials, each written for real people, not researchers. We’re tracking 497 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06161636Recruiting
Studying hand movement to diagnose Parkinson's early
This trial looks at how analyzing hand movements might help doctors tell the difference between Parkinson's disease and other similar conditions early on. It may help improve diagnosis so patients get the right care sooner.
Montreal, QuebecAges 50–75 - NCT06167681RecruitingPhase 1/Phase 2
Cell Therapy NouvNeu001 for Parkinson's Disease
This trial tests a new cell therapy called NouvNeu001 for Parkinson's disease. It involves a one-time brain surgery to deliver the treatment, and researchers will check if it's safe and helps with symptoms.
Beijing, Beijing MunicipalityAges 50–75 - NCT06234995RecruitingPhase 4
Brain activity and movement control in Parkinson's
This study looks at how the brain controls movement in people with Parkinson's disease, including those who have had deep brain stimulation (DBS) surgery. It involves recording brain activity and may help doctors understand how to improve treatment.
Atlanta, GeorgiaAges 45–75 - NCT06295614Recruiting
ARC-IM therapy for walking problems in Parkinson's
This study tests a new therapy called ARC-IM to help with walking issues like freezing or balance problems in people with Parkinson's. It aims to see if the therapy is safe and can improve movement.
Lausanne, Canton of VaudAges 18 years+ - NCT06356662RecruitingPhase 1
Testing tenofovir for Parkinson's disease
This trial is testing if a medicine called tenofovir, usually used for HIV and hepatitis B, can help people with early-stage Parkinson's disease. It's for people who are under 65 and have no other major health issues.
Hangzhou, ZhejiangAges 18–65 - NCT06383247Recruiting
Precision TMS for parkinson's motor symptoms
This trial tests a precise form of brain stimulation (called TMS) to see if it can improve movement problems like stiffness, slowness, or tremors in people with Parkinson's disease. Participants must have a stable medication routine and no metal implants or brain surgery history.
Hefei, AnhuiAges 40 years+ - NCT06386497Recruiting
Bed for better sleep in Parkinson's disease
This study tests a special bed (Somnomat Casa) to help improve sleep in people with Parkinson's disease. It looks at whether the bed is comfortable and acceptable to use.
BernAges 18–85 - NCT06388863Recruiting
Fecal transplant for constipation in Parkinson's disease
This study tests whether a treatment called fecal microbiota transplantation (FMT) can help relieve constipation in people with Parkinson's disease. FMT uses healthy donor stool to improve gut bacteria, which may ease constipation and possibly improve Parkinson's symptoms.
Shanghai, Shanghai MunicipalityAges 40–75 - NCT06399731Recruiting
Brain stimulation for mild thinking problems in Parkinson's
This trial tests if non-invasive brain stimulation can help with memory and thinking problems (mild cognitive impairment) in people with Parkinson's disease. It uses magnetic pulses and mild electrical current to stimulate the brain over a few weeks.
Amsterdam, North HollandAges Any age - NCT06456684Recruiting
AV133 PET scan study in early Parkinson's disease
This study uses a special PET scan to look at a protein (VMAT2) in the brain that is linked to Parkinson's disease. It helps researchers understand early changes in people with newly diagnosed Parkinson's or those at high risk of developing it.
Beijing, Beijing MunicipalityAges 30 years+ - NCT06464029Recruiting
Balance and walking study in Parkinson's disease
This study looks at balance problems in people with Parkinson's disease. It uses simple tests to understand what causes trouble with standing and walking, which may help find better treatments.
Minneapolis, MinnesotaAges 45–80 - NCT06466525RecruitingPhase 1
Study of LBT-3627 in healthy people and those with Parkinson's
This trial tests a new drug called LBT-3627. It is given at increasing doses to see if it is safe and how the body processes it. The study includes both healthy people and those with Parkinson's disease, with a focus on people aged 30 to 89.
Melbourne, VictoriaAges 30–89 - NCT06506058Recruiting
Study on balance and brain in Parkinson's freezing of gait
This study looks at how the balance system and brain work together to cause freezing of gait in Parkinson's disease. By understanding these factors, researchers hope to find better ways to help people walk more steadily.
Minneapolis, MinnesotaAges 21–80 - NCT06536478Recruiting
Exercise for posture and flexibility in Parkinson's disease
This study tests whether a special exercise program can improve your posture, flexibility, and spine health. It is designed for people with mild to moderate Parkinson's disease who are stable on their medications.
HsinchuAges 30–85 - NCT06573762Recruiting
Home monitoring for Parkinson's disease
This study uses a Fitbit to track movement and symptoms from home. It is for people who are newly referred or recently diagnosed with Parkinson's disease.
Iowa City, IowaAges 50–110 - NCT06582355Recruiting
Brain training with MRI for Parkinson's disease
This study tests whether a brain-training technique called neurofeedback can help people with Parkinson's disease. You will learn to control certain brain signals while having an MRI scan, which may improve your symptoms.
CologneAges 18 years+ - NCT06591975Recruiting
Upper extremity function and balance in Parkinson's disease
This study looks at how arm and hand function relates to balance and mobility in people with Parkinson's disease. Understanding this link may lead to better therapy approaches.
SivasAges 18–80 - NCT07381751Recruiting
AI assessment of Parkinson's motor symptoms via video
This study uses artificial intelligence to analyze videos of standard motor tests (MDS-UPDRS Part III) for people with Parkinson's disease. It aims to see if AI can reliably assess your symptoms, which could lead to easier, more accessible monitoring in the future.
Hong KongAges 18–95 - NCT06629389RecruitingPhase 2
Cannabidiol (Kanbis) for Parkinson's symptoms
This trial tests whether cannabidiol (CBD) can help with Parkinson's disease symptoms. Researchers want to see if it's safe and effective for people with mild to moderate Parkinson's who are already on stable medications.
Mendoza, Mendoza ProvinceAges 40–80 - NCT06630702Recruiting
Spinal cord stimulation for freezing gait in advanced Parkinson's
This trial tests if a small device placed near your spine (spinal cord stimulation) can help improve freezing of gait in people with advanced Parkinson's whose medicines aren't enough. It also aims to reduce leg pain if you have it.
Hsinchu, Hsinchu CityAges 40–85 - NCT06646510Recruiting
Electrical stimulation for resting tremors in Parkinson's
This trial tests whether gentle electrical stimulation to the skin (called sensory electrical stimulation) can help reduce resting tremors in people with Parkinson's disease. Resting tremors are shaking that happens when your muscles are relaxed, like when your hands are in your lap.
GizaAges 45–60 - NCT06663826Recruiting
Digital diagnostic devices for Parkinson's disease
This study tests digital devices that may help track Parkinson's symptoms using eye movements and balance. It is designed for people with Parkinson's or related conditions who have trouble with walking (freezing) and can walk for at least 5 minutes.
Zurich, Canton of ZurichAges Any age - NCT06692920Recruiting
Parkinson's brain signals study during DBS surgery
This study looks at brain signals in people with Parkinson's who are already scheduled for Deep Brain Stimulation (DBS) surgery. The goal is to better understand how certain brain pathways work, which could lead to improved treatments.
Minneapolis, MinnesotaAges 21–75 - NCT06707402Recruiting
Community walking program for people with Parkinson's
This study tests whether a 24-week community walking program (brisk walking) can help people with Parkinson's disease who have trouble walking. If you join, you will walk regularly with others in your community and have your walking ability checked before and after.
Aarhus CAges 40 years+
Hear when a new PARKINSON DISEASE (Disorder) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinson disease (disorder)?
- Yes. Clin2 currently lists 497 recruiting parkinson disease (disorder) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinson disease (disorder) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinson disease (disorder) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.